The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable

In the USA, an interchangeability designation provides biosimilar sponsors with a pathway for achieving what is standard for small-molecule generics: pharmacy-level auto-substitution for an innovator. No other major health authority links interchangeability to automatic substitution, as all require...

Descripción completa

Detalles Bibliográficos
Autores principales: Afzali, Anita, Furtner, Daniel, Melsheimer, Richard, Molloy, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107170/
https://www.ncbi.nlm.nih.gov/pubmed/33745111
http://dx.doi.org/10.1007/s12325-021-01688-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107170/
https://www.ncbi.nlm.nih.gov/pubmed/33745111
http://dx.doi.org/10.1007/s12325-021-01688-9

Ejemplares similares